|
Familial and Early Onset Colorectal Cancer
|
5R01CA072851-21
|
$372,400
|
$372,400
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas
|
5R01CA184585-04
|
$802,610
|
$401,305
|
NEUHAUSEN, SUSAN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
$1,466
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
$2,500
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$48,934
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A National Curriculum in Cancer Genomics for Residents and Medical Students
|
2R25CA168544-06
|
$255,425
|
$127,713
|
HASPEL, RICHARD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Breast Cancer Family Registry Cohort
|
3UM1CA164920-05S1
|
$91,762
|
$45,881
|
JOHN, ESTHER
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-10
|
$614,290
|
$614,290
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome
|
5R01CA143167-07
|
$407,577
|
$407,577
|
HILL, DANA
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
$600
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
$115,928
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S1
|
$112,500
|
$1,125
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
DF/HCC SPORE in Prostate Cancer
|
5P50CA090381-15
|
$2,300,000
|
$943,000
|
LODA, MASSIMO
|
DANA-FARBER CANCER INST
|
|
Genetics of Prostate Cancer in Africa
|
5U01CA184374-03
|
$1,707,746
|
$1,707,746
|
REBBECK, TIMOTHY
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA015704-42S1
|
$249,999
|
$5,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S2
|
$125,000
|
$2,500
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S3
|
$58,085
|
$1,162
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S4
|
$70,220
|
$1,404
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-42
|
$9,559,285
|
$191,186
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Methods for Integrating Functional Data into Complex Disease Genetic Analyses
|
5R01CA189532-03
|
$464,176
|
$464,176
|
HSU, LI
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
3R01CA054498-25S1
|
$44,259
|
$8,852
|
LEISENRING, WENDY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical Significance of MHC Haplotypes in HCT
|
5R01CA100019-15
|
$335,005
|
$335,005
|
PETERSDORF, EFFIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Barrett's Esophagus: Predictors of Progression
|
5P01CA091955-14
|
$1,731,544
|
$865,772
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Isothermal Chain Reaction (ICR) Detection of SNP Biomarkers for Ovarian Cancer Pont-of-Care Testing and Risk Stratification
|
3R43CA195841-01A1S1
|
$50,000
|
$25,000
|
MANCEBO, RICARDO
|
GENENDEAVOR, LLC
|
|
A Question Prompt List to Promote Communication in Genomic Medicine
|
5R21CA201827-02
|
$172,029
|
$86,015
|
O'NEILL, SUZANNE
|
GEORGETOWN UNIVERSITY
|
|
Evolving Model of Cancer Susceptibility Testing: Clinical Decisions & Outcomes
|
5R21CA194965-02
|
$169,106
|
$169,106
|
SCHWARTZ, MARC
|
GEORGETOWN UNIVERSITY
|
|
Georgetown University Lombardi Cancer Center Support Grant
|
3P30CA051008-24S1
|
$166,654
|
$3,333
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Georgetown University Lombardi Cancer Center Support Grant
|
5P30CA051008-24
|
$2,258,441
|
$45,169
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
2/2 The GUIDE Cancer Research Training Project
|
3P20CA202907-03S1
|
$52,412
|
$26,206
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
2/2 The GUIDE Cancer Research Training Project
|
5P20CA202907-03
|
$174,056
|
$87,028
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
|
5R01CA185357-04
|
$398,393
|
$398,393
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
2P30CA006973-54
|
$7,060,038
|
$70,600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S1
|
$125,000
|
$1,250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S2
|
$60,000
|
$600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S3
|
$25,000
|
$250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Molecular Genetics of Melanoma
|
5K24CA149202-08
|
$171,081
|
$171,081
|
TSAO, HENSIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Risk and penetrance of mutations from breast cancer testing panels.
|
5R01CA192393-04
|
$1,263,145
|
$1,263,145
|
COUCH, FERGUS
|
MAYO CLINIC ROCHESTER
|
|
BRCA1 and BRCA2 missense mutations and breast cancer risk
|
5U01CA116167-10
|
$527,128
|
$527,128
|
COUCH, FERGUS
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S1
|
$60,000
|
$1,800
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S2
|
$75,000
|
$2,250
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S3
|
$749,911
|
$22,497
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-43
|
$5,815,389
|
$174,462
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Clinic SPORE in Pancreatic Cancer
|
5P50CA102701-14
|
$2,300,000
|
$2,300,000
|
PETERSEN, GLORIA
|
MAYO CLINIC ROCHESTER
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
5U54CA163069-07
|
$1,414,315
|
$28,286
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
Robust Predictor of Breast Cancer Risk
|
1R41CA217383-01A1
|
$300,000
|
$300,000
|
OSTRER, HARRY
|
MORGAN AND MENDEL GENOMICS, INC.
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$519,415
|
$103,883
|
Ambs, Stefan
|
CCR (NCI)
|
|
Antibody-based therapeutics and vaccines against AIDS
|
ZIA BC 011155
|
$220,413
|
$44,083
|
Dimitrov, Dimiter
|
CCR (NCI)
|
|
Genetic Modifiers of Initiation and Progression of Mammary Cancer
|
ZIA BC 011255
|
$1,232,548
|
$123,255
|
Hunter, Kent
|
CCR (NCI)
|
|
Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC)
|
ZIA BC 011287
|
$418,573
|
$209,286
|
Kebebew, Electron
|
CCR (NCI)
|
Total relevant funding to Genetic Testing for this search: $25,304,806
|